{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:37:44Z","timestamp":1780814264917,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2019,12]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n New onset atrial fibrillation is the most commonly encountered arrhythmia in critically unwell patients with a reported incidence of 4% to 29%. The occurrence of new onset atrial fibrillation may precipitate acute heart failure and lead to thromboembolic complications as well as being associated with increased in-hospital and in intensive care unit (ICU) mortality. Despite being common, much of our current knowledge regarding the treatment of new onset atrial fibrillation comes from patients with chronic atrial fibrillation or post cardiac surgery. It is unclear if management strategies in these patient cohorts can be applied to new onset atrial fibrillation in the general ICU. This protocol for a systematic review and network meta-analysis aims to address this uncertainty and define what is the most effective management strategy for the treatment of new onset atrial fibrillation (NOAF) in acutely unwell adult patients.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In this systematic review and network meta-analysis, we plan to search electronic databases (Cochrane Central Register of Controlled Trials [CENTRAL], MEDLINE, EMBASE, Science Citation Index Expanded on Web of Science and relevant trial registries) for relevant randomised and non-randomised trials. Citations will be reviewed by title, abstract and full text by two independent reviewers and disagreement resolved by discussion and a third independent reviewer, if necessary. The Cochrane Risk of Bias tool will be used to assess risk of bias in randomised trials and the Risk of Bias in Nonrandomised Studies of Interventions (ROBINS-I) tool will be used for non-randomised studies. Statistical analysis will be carried out using R package meta and netmeta. We will first conduct a pairwise meta-analysis. If conditions for indirect comparison are satisfied and suitable data are available, we will conduct network meta-analysis using frequentist methodology. Treatments will be ranked according to efficacy with associated P-scores. We will assess the quality of the evidence in the pairwise using GRADE methodology and network meta-analysis comparisons in the CINeMA module in R package meta.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n Our review will be the first to assess direct and indirect evidence to assess the efficacy and rank the treatments available for new onset atrial fibrillation in critically unwell patients. Our review findings will be applicable to the care of people in a range of acute settings including, ICU, the emergency department and acute medical units.<\/jats:p>\n <\/jats:sec>\n \n Systematic review registration<\/jats:title>\n PROSPERO registry number: CRD42019121739.<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s13643-019-1149-7","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:33:32Z","timestamp":1572262412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protocol for a systematic review and network meta-analysis of the management of new onset atrial fibrillation in critically unwell adult patients"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-3297","authenticated-orcid":false,"given":"Brian W.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruaraidh","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Shen","family":"Chean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny F.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronagh","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg D.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"issue":"3","key":"1149_CR1","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/cc9057","volume":"14","author":"R Meierhenrich","year":"2010","unstructured":"Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, B\u00f6gelein D, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care. 2010;14(3):R108. \n https:\/\/doi.org\/10.1186\/cc9057\n \n .","journal-title":"Crit Care"},{"issue":"6","key":"1149_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","volume":"18","author":"S Kuipers","year":"2014","unstructured":"Kuipers S, Mc P, Klouwenberg K, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care. 2014;18(6):688. \n https:\/\/doi.org\/10.1186\/s13054-014-0688-5\n \n .","journal-title":"Crit Care"},{"issue":"5","key":"1149_CR3","doi-asserted-by":"publisher","first-page":"e0127168","DOI":"10.1371\/journal.pone.0127168","volume":"10","author":"C Guenancia","year":"2015","unstructured":"Guenancia C, Binquet C, Laurent G, Vinault S, Bruy\u00e8re R, Prin S, et al. Incidence and predictors of new-onset atrial fibrillation in septic shock patients in a medical ICU: data from 7-day Holter ECG monitoring. PLoS One. 2015;10(5):e0127168. \n https:\/\/doi.org\/10.1371\/journal.pone.0127168\n \n .","journal-title":"PLoS One"},{"issue":"1","key":"1149_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40560-015-0085-4","volume":"3","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Fujii T, Uchino S, Takinami M. Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review. J Intensive Care. 2015;3(1):19. \n https:\/\/doi.org\/10.1186\/s40560-015-0085-4\n \n .","journal-title":"J Intensive Care"},{"key":"1149_CR5","unstructured":"Gilligan, D M, Ellenbogen, K and Epstein, E. Atrial fibrillation: management CG180. In: Guidance and guidelines. National Institute for Care and Health Excellence. 2018. \n https:\/\/www.nice.org.uk\/guidance\/cg180\n \n . Last accessed: 26 June 2019."},{"issue":"10","key":"1149_CR6","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1097\/CCM.0000000000001166","volume":"43","author":"CM Shaver","year":"2015","unstructured":"Shaver CM, Chen W, Janz DR, May AK, Darbar D, Bernard GR, et al. Atrial fibrillation is an independent predictor of mortality in critically ill patients. Crit Care Med. 2015;43(10):2104\u201311. \n https:\/\/doi.org\/10.1097\/CCM.0000000000001166\n \n .","journal-title":"Crit Care Med"},{"key":"1149_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","volume":"195","author":"PMC Klein Klouwenberg","year":"2017","unstructured":"Klein Klouwenberg PMC, Frencken JF, Kuipers S, Ong DSY, Peelen LM, Van Vught LA, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis a cohort study. Am J Respir Crit Care Med. 2017;195:205\u201311. \n https:\/\/doi.org\/10.1164\/rccm.201603-0618OC\n \n .","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"1149_CR8","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1001\/jama.2011.1615","volume":"306","author":"AJ Walkey","year":"2011","unstructured":"Walkey AJ, Soylemez Wiener R, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306(20):2248\u201354. \n https:\/\/doi.org\/10.1001\/jama.2011.1615\n \n .","journal-title":"JAMA"},{"key":"1149_CR9","doi-asserted-by":"publisher","first-page":"697.e1","DOI":"10.1016\/j.jcrc.2014.03.029","volume":"4","author":"SS Makrygiannis","year":"2014","unstructured":"Makrygiannis SS, Margariti A, Rizikou D, Lampakis M, Vangelis S, Ampartzidou OS, et al. Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patient. J Crit Care. 2014;4:697.e1\u20135. \n https:\/\/doi.org\/10.1016\/j.jcrc.2014.03.029\n \n .","journal-title":"J Crit Care"},{"issue":"14","key":"1149_CR10","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","volume":"291","author":"JP Mathew","year":"2004","unstructured":"Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720\u20139. \n https:\/\/doi.org\/10.1001\/jama.291.14.1720\n \n .","journal-title":"JAMA"},{"key":"1149_CR11","unstructured":"Alpert JS, Calkins H, Joaquin CE, Joseph CJR FaccC, Jamie CB, Ellinor PT, et al. AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. JAC. 2014. \n https:\/\/www.acc.org\/~\/media\/Non-Clinical\/Files-PDFs-Excel-MS-Word-etc\/Tools%20and%20Practice%20Support\/Quality%20Programs\/Anticoag-10-14\/GuidelinesAndBackground\/1%20January%20ACC%20AHA%20HRS%202014%20Afib%20Guidelines.pdf?la=en&hash=045CC1497924765E355CE669A9A905994645FBCE\n \n . Accessed 28 June 2019."},{"key":"1149_CR12","doi-asserted-by":"crossref","unstructured":"January CT, Group W, Samuel Wann L, Chair V, Calkins H, Group Member W, et al. AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation. JAC 2019. \n https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000665\n \n . Accessed: 28 June 2019.","DOI":"10.1016\/j.hrthm.2019.01.024"},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.g36","volume":"348","author":"C Jones","year":"2014","unstructured":"Jones C, Pollit V, Fitzmaurice D, Cowan C. The management of atrial fibrillation: summary of updated NICE guidance. BMJ. 2014;348:1\u20138. \n https:\/\/doi.org\/10.1136\/bmj.g36\n \n .","journal-title":"BMJ"},{"issue":"7","key":"1149_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","volume":"43","author":"B Olshansky","year":"2004","unstructured":"Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O\u2019neill G, Sharma A, et al. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study approaches to control rate in atrial fibrillation. J Am Coll Cardiol. 2004;43(7):1201\u20138. \n https:\/\/doi.org\/10.1016\/j.jacc.2003.11.032\n \n .","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1149_CR15","first-page":"118","volume":"10","author":"I van Gelder","year":"2002","unstructured":"van Gelder I, Hagens V, Kingma J, Bosker H, Kingma T, Veeger N, et al. Rate control versus electrical cardioversion for atrial fibrillation: a randomised comparison oftwo treatment strategies concerning morbidity, mortality, quality oflife and cost-benefit-the RACE study design. Neth Heart J. 2002;10(3):118\u201324.","journal-title":"Neth Heart J"},{"key":"1149_CR16","doi-asserted-by":"publisher","first-page":"e3716","DOI":"10.7717\/peerj.3716","volume":"5","author":"ID Welters","year":"2017","unstructured":"Welters ID, Shen Chean C, Mcauley D, Gordon A. Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey. Peer J. 2017;5:e3716. \n https:\/\/doi.org\/10.7717\/peerj.3716\n \n .","journal-title":"Peer J"},{"key":"1149_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1378\/chest.15-0959","volume":"149","author":"AJ Walkey","year":"2016","unstructured":"Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice patterns and outcomes of treatments for atrial fibrillation during sepsis. Chest. 2016;149:74\u201383. \n https:\/\/doi.org\/10.1378\/chest.15-0959\n \n .","journal-title":"Chest"},{"key":"1149_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(06)68037-9","volume":"367","author":"S Nattel","year":"2006","unstructured":"Nattel S, Opie LH. Controversies in cardiology 3 controversies in atrial fibrillation. Lancet. 2006;367:262\u201372.","journal-title":"Lancet"},{"issue":"3","key":"1149_CR19","doi-asserted-by":"publisher","first-page":"326.e1","DOI":"10.1016\/j.jcrc.2011.10.011","volume":"27","author":"S Kanji","year":"2012","unstructured":"Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012;27(3):326.e1\u20138. \n https:\/\/doi.org\/10.1016\/j.jcrc.2011.10.011\n \n .","journal-title":"J Crit Care"},{"key":"1149_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc6136","volume":"11","author":"ME Sleeswijk","year":"2007","unstructured":"Sleeswijk ME, Van Noord T, Tulleken JE, Ligtenberg JJM, Girbes ARJ, Zijlstra JG. Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients: a clinical framework. Crit Care. 2007;11:1\u201310. \n https:\/\/doi.org\/10.1186\/cc6136\n \n .","journal-title":"Crit Care"},{"issue":"4","key":"1149_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139. \n https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135\n \n .","journal-title":"Ann Intern Med"},{"key":"1149_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777\u201384.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1149_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/emermed-2015-204847","volume":"33","author":"GD Perkins","year":"2016","unstructured":"Perkins GD, Lockey AS, de Belder MA, Moore F, Weissberg P, Gray H. National initiatives to improve outcomes from out-of-hospital cardiac arrest in England. Emerg Med J. 2016;33(7):448\u201351. \n https:\/\/doi.org\/10.1136\/emermed-2015-204847\n \n .","journal-title":"Emerg Med J"},{"key":"1149_CR24","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369\u2013429. \n https:\/\/doi.org\/10.1093\/eurheartj\/ehq278\n \n .","journal-title":"Eur Heart J"},{"key":"1149_CR25","doi-asserted-by":"crossref","unstructured":"Higgins J and Thomas J. Cochrane handbook for systematic reviews of interventions. Cochrane Training 2018. \n https:\/\/training.cochrane.org\/handbook\n \n . Accessed: 28 June 2019.","DOI":"10.1002\/9781119536604"},{"key":"1149_CR26","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. \n https:\/\/doi.org\/10.1136\/bmj.i4919\n \n .","journal-title":"BMJ"},{"key":"1149_CR27","unstructured":"Developing NICE guidelines: the manual. In NICE guidelines: the manual. Process and methods. 2014. \n https:\/\/www.nice.org.uk\/process\/pmg20\/resources\/developing-nice-guidelines-the-manual-pdf-72286708700869\n \n . Accessed 28 June 2019."},{"issue":"2","key":"1149_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397. \n https:\/\/doi.org\/10.1002\/jrsm.1037\n \n .","journal-title":"Res Synth Methods"},{"key":"1149_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163\u201371. \n https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.016\n \n .","journal-title":"J Clin Epidemiol"},{"key":"1149_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:58. \n https:\/\/doi.org\/10.1186\/s12874-015-0060-8\n \n .","journal-title":"BMC Med Res Methodol"},{"key":"1149_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Sch\u00fcnemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al. A GRADE working group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:1\u201310. \n https:\/\/doi.org\/10.1136\/bmj.g5630\n \n .","journal-title":"BMJ"},{"issue":"7","key":"1149_CR32","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti G, Del Giovane C, Chaimani A, Caldwell DM, T Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014;9(7):e99682. \n https:\/\/doi.org\/10.1371\/journal.pone.0099682\n \n .","journal-title":"PLoS One"},{"issue":"2","key":"1149_CR33","doi-asserted-by":"publisher","first-page":"e0212650","DOI":"10.1371\/journal.pone.0212650","volume":"14","author":"FS Tonin","year":"2019","unstructured":"Tonin FS, Borba HH, Id AMM, Wiens A, Id FF, Pontarolo R. Description of network meta-analysis geometry: a metrics design study. PLoS One. 2019;14(2):e0212650. \n https:\/\/doi.org\/10.1371\/journal.pone.0212650\n \n .","journal-title":"PLoS One"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-019-1149-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:45:27Z","timestamp":1603759527000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-019-1149-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1186\/s13643-019-1149-7","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}